Member News

Strickland to hold new professorship; Blind recognized by genetics society

ASBMB Today Staff
April 5, 2021

Strickland to hold new professorship

Sidney Strickland

Sidney Strickland, a professor, dean of graduate and postgraduate studies, and vice president for educational affairs at Rockefeller University, will be the first person to hold that university’s new Fisher Center named professorship for neurodegenerative disease research.

Strickland’s lab studies the contribution of vascular dysfunction to the development of Alzheimer’s disease; they found that beta-amyloid protein can promote clotting and inflammation in the brain by interacting with fibrinogen and activating coagulation factor FXII. The work has suggested new molecular mechanisms for the widely studied beta-amyloid protein to contribute to Alzheimer’s pathogenesis and has linked the disease to other common maladies of aging, such as hypertension and cardiovascular disease.

The position, funded by the Fisher Center for Alzheimer’s Research Foundation, will support research into neurodegenerative diseases. It extends the Fisher Center’s partnership with Rockefeller University; the university is also home to the foundation’s flagship lab of 40 scientists focused on Alzheimer’s disease. Strickland has been a member of the Fisher Center’s neuroscience advisory committee since 2019.

Blind recognized by GSA

Raymond Blind

Raymond D. Blind, an assistant professor at Vanderbilt University, was named in early March a member of the inaugural cohort for the Genetics Society of America’s Presidential Membership Initiative. This competitive program aims to diversify the GSA membership while providing professional-development programming and support for early-career scientists.

Blind’s lab studies how nuclear inositides and inositols regulate chromatin-bound proteins. He recently completed a two-year stint as a junior associate editor for the Journal of Lipid Research, an American Society for Biochemistry and Molecular Biology publication. (Read our short profile.)

Blind will give a talk titled “The acyl chains of phosphoinositides alter the structure and function of nuclear receptor steroidogenic factor-1” at a special session on lipid diversity and disease at the 2021 ASBMB Annual Meeting. The session will be at 2:15 p.m. Eastern on Thursday, April 29.


 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Ahmed named Goldwater Scholar
Member News

Ahmed named Goldwater Scholar

June 9, 2025

She will receive up to $7,500 for tuition, fees, books and room and board each year until she graduates.

In memoriam: Norman Meadow
In Memoriam

In memoriam: Norman Meadow

May 26, 2025

He was a professor of biochemistry at Johns Hopkins University, who studied the bacterial phosphotransferase system and was an ASBMB member for more than 30 years.

Meet Lan Huang
Interview

Meet Lan Huang

May 19, 2025

Molecular & Cellular Proteomics associate editor uses crosslinking mass spec to study protein–protein interactions to find novel therapeutics.

Meet Shannon Reilly
Profile

Meet Shannon Reilly

May 12, 2025

The JLR junior associate editor discusses the role of adipocytes in obesity at Weill Cornell Medical School.

Meet Donita Brady
Interview

Meet Donita Brady

May 8, 2025

Donita Brady is an associate professor of cancer biology and an associate editor of the Journal of Biological Chemistry, who studies metalloallostery in cancer.

Glyco get-together exploring health and disease
Interview

Glyco get-together exploring health and disease

May 7, 2025

Meet the co-chairs of the 2025 ASBMB meeting on O-GlcNAcylation to be held July 10–13, 2025, in Durham, North Carolina. Learn about the latest in the field and meet families affected by diseases associated with this pathway.